16-06-2018 | Hypoglycemia | Slideset | Gallery
Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes
This slide set outlines the extension phase of the REPLACE trial, which shows that the significant reductions in hypoglycemia obtained in patients with insulin-dependent type 2 diabetes after 6 months of flash glucose monitoring use were sustained over an additional 6 months.
Read the full-text article here
Funded by an educational grant from Abbott Diabetes Care
Advertisement